* Laboratory Corporation of America Holdings LH.N reported
quarterly adjusted earnings of $3.82 per share for the quarter
ended in March. The mean expectation of fourteen analysts for
the quarter was for earnings of $3.96 per share.
* Revenue fell 3.1% to $3.78 billion from a year ago;
analysts
expected $3.69 billion.
* Laboratory Corporation of America Holdings's reported EPS
for
the quarter was $2.39.
* The mean earnings estimate of analysts had fallen by
about 5.3%
in the last three months.
* In the last 30 days, one analyst negatively revised an
earnings
estimate
* Laboratory Corporation of America Holdings shares
had risen
by 1.3% this quarter and lost 1.3% so far this year.
* The company reported quarterly net income of $212.9
million.
* Wall Street's median 12-month price target for Laboratory
Corporation of America Holdings is $288.00
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 13 "strong buy" or "buy," 4
"hold" and no "sell" or "strong sell."
This summary was machine generated from LSEG Refinitiv data
April 25 at 01:30 p.m. UTC. All figures in US dollars unless
otherwise stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Mar. 31 2023 3.96 3.82 Missed
Dec. 31 2022 4.10 4.14 Beat
Sep. 30 2022 4.67 4.68 Beat
Jun. 30 2022 4.70 4.95 Beat